United Therapeutics Corporation Payments to Acquire Businesses, Gross
United Therapeutics Corporation (UTHR) reported Payments to Acquire Businesses, Gross of $3.55 million for the 12-month period ending 2011-12-31, per its 10-K filed 2014-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2014-02-25
- United Therapeutics Corporation payments to acquire businesses, gross for the quarter ending 2011-12-31 was $0.00.
- United Therapeutics Corporation payments to acquire businesses, gross for the quarter ending 2009-12-31 was $190.00K.
- United Therapeutics Corporation payments to acquire businesses, gross for fiscal 2011 was $3.55M.
- United Therapeutics Corporation payments to acquire businesses, gross for fiscal 2009 was $3.57M.
| Period end | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $3.55M 10-K · filed 2014-02-25 | |
| 2011-09-30 | $3.55M 10-Q · filed 2012-11-01 | ||
| 2009-12-31 | $190.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $3.57M 10-K · filed 2012-02-28 | |
| 2009-09-30 | $3.38M 10-Q · filed 2010-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |